MSB 7.69% $1.19 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-121

  1. 5,071 Posts.
    lightbulb Created with Sketch. 567

    Totally share everyones disbelief, angst and distress for those kids and familys.

    I regard myself as a logical person and all this makes no sense. They, the FDA, could have issued a conditional approval.

    They have enough evidence – so don’t know what another trial will offer or prove; and and in that have set a very dangerous precedent, which also, makes me believe there are other influences going on.

    If they don’t get approval, I believe there is a legal battle that MSB will have to have because it means over a decade of research and development gone to waste, this as I have read that some have taken to FDA to court and won.

    I still have to believe that all will be ok in the end…. And shame on them for asking for another trial for kids; which will says to parents you have less than 5% chance of your child surviving if there is to be a placebo trial.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.19
Change
0.085(7.69%)
Mkt cap ! $1.358B
Open High Low Value Volume
$1.10 $1.20 $1.09 $13.21M 11.37M

Buyers (Bids)

No. Vol. Price($)
1 15000 $1.19
 

Sellers (Offers)

Price($) Vol. No.
$1.19 75212 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.